Contents -- Acknowledgments -- Abbreviations -- Introduction: Making Sense of Emerging Technologies -- Part 1: Hindsight Learnings -- 1 GM Foods in Hindsight -- 2 Patentable Subject Matter: Who Owns What Knowledge? -- 3 Patents in the Public Sphere: Public Perceptions and Biotechnology Patents -- Part 2: Foresight Applications -- (Transgenic) Animal Farm -- 4 Of Biotechnology and Blind Chickens -- 5 Transgenic Salmon: Regulatory Oversight of an Anticipated Technology -- Fields of Pharmas: Plant Molecular Farming -- 6 The Emerging Technology of Plant Molecular Farming -- 7 Policy and Regulatory Challenges for Plant-Made Pharmaceuticals in the United States -- 8 Forestalling Liabilities? Stakeholder Participation and Regulatory Development -- In the Stem Cell Fields -- 9 When Human Dignity Is Not Enough: Embryonic Stem Cell Research and Human Cloning in Canada -- Drugs-Up Close and Personal: Engaging Pharmacogenomics -- 10 Banking on Trust: Issues of Informed Consent in Pharmacogenetic Research -- 11 Pharmacogenomic Promises: Reflections on Semantics, Genohype, and Global Justice -- 12 Envisioning Race and Medicine: BiDil and the Insufficient Match between Social Groups and Genotypes -- Is Small Really Beautiful? Does Size Matter? Nanotechnologies -- 13 Nanotechnology and Human Imagination -- 14 Nanotechnology: The Policy Challenges -- Part 3: Governance Challenges and Emerging Technologies -- 15 Technology, Democracy, and Ethics: Democratic Deficit and the Ethics of Public Engagement -- 16 Impact Assessments and Emerging Technologies: From Precaution to "Smart Regulation"? -- 17 Technology Ownership and Governance: An Alternative View of IPRs -- Conclusion: Reflections on Emerging Technologies -- List of Contributors -- Index -- A -- B -- C -- D -- E -- G -- H -- I -- K -- M -- N -- O -- P -- R -- S -- T -- U -- V -- W -- X.